ID Business Solutions (IDBS), leading provider of integrated data management, analysis and decision-making software for the pharmaceutical, biotechnology and animal health industries, today announced several collaborations in Australia. CSIRO, the Walter and Eliza Hall Institute and Alchemia are among the organisations that have adopted IDBS’ ActivityBase software suite to manage their chemical and biological drug discovery data. Neil Kipling, Chairman and CEO of IDBS, commented: “The biotechnology sector in Australia is growing, and this uptake of ActivityBase by such pre-eminent companies in Australia is indicative of IDBS' leadership in the market.” He continued, “A solid foundation of data integration is an integral part of efficient discovery operations, as is the ability for multiple departments to share essential information. We are pleased to be able to fulfill this need.”
